Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb 20;12(2):235.
doi: 10.3390/v12020235.

Bacteriophages for Chronic Wound Treatment: from Traditional to Novel Delivery Systems

Affiliations
Review

Bacteriophages for Chronic Wound Treatment: from Traditional to Novel Delivery Systems

Ana M Pinto et al. Viruses. .

Abstract

The treatment and management of chronic wounds presents a massive financial burden for global health care systems, with significant and disturbing consequences for the patients affected. These wounds remain challenging to treat, reduce the patients' life quality, and are responsible for a high percentage of limb amputations and many premature deaths. The presence of bacterial biofilms hampers chronic wound therapy due to the high tolerance of biofilm cells to many first- and second-line antibiotics. Due to the appearance of antibiotic-resistant and multidrug-resistant pathogens in these types of wounds, the research for alternative and complementary therapeutic approaches has increased. Bacteriophage (phage) therapy, discovered in the early 1900s, has been revived in the last few decades due to its antibacterial efficacy against antibiotic-resistant clinical isolates. Its use in the treatment of non-healing wounds has shown promising outcomes. In this review, we focus on the societal problems of chronic wounds, describe both the history and ongoing clinical trials of chronic wound-related treatments, and also outline experiments carried out for efficacy evaluation with different phage-host systems using in vitro, ex vivo, and in vivo animal models. We also describe the modern and most recent delivery systems developed for the incorporation of phages for species-targeted antibacterial control while protecting them upon exposure to harsh conditions, increasing the shelf life and facilitating storage of phage-based products. In this review, we also highlight the advances in phage therapy regulation.

Keywords: bacteriophage; biofilms; chronic wound; delivery systems; phage therapy; wound healing.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Prevalence of wound types in the Medicare population (data from the year 2014) [25].
Figure 2
Figure 2
Phases of wound healing [4].
Figure 3
Figure 3
The wound infection continuum [18,30].
Figure 4
Figure 4
Steps leading to bacterial biofilm formation Adapted from [60].
Figure 5
Figure 5
Phage delivery systems to wounds.

References

    1. Lazarus G.S., Cooper D.M., Knighton D.R., Margolis D.J., Percoraro R.E., Rodeheaver G., Robson M.C. Definitions and guidelines for assessment of wounds and evaluation of healing. Wound Repair Regen. 1994;2:165–170. doi: 10.1046/j.1524-475X.1994.20305.x. - DOI - PubMed
    1. Siddiqui A.R., Bernstein J.M. Chronic wound infection: Facts and controversies. Clin. Dermatol. 2010;28:519–526. doi: 10.1016/j.clindermatol.2010.03.009. - DOI - PubMed
    1. Hu M.S., Borrelli M.R., Lorenz H.P., Longaker M.T., Wan D.C. Mesenchymal stromal cells and cutaneous wound healing: A comprehensive review of the background, role, and therapeutic potential. Stem Cells Int. 2018;2018:1–13. doi: 10.1155/2018/6901983. - DOI - PMC - PubMed
    1. Aljghami M.E., Saboor S., Amini-Nik S. Emerging innovative wound dressings. Ann. Biomed. Eng. 2019;47:659–675. doi: 10.1007/s10439-018-02186-w. - DOI - PubMed
    1. Mustoe T.A., O’Shaughnessy K., Kloeters O. Chronic wound pathogenesis and current treatment strategies: A unifying hypothesis. Plast. Reconstr. Surg. 2006;117:35S–41S. doi: 10.1097/01.prs.0000225431.63010.1b. - DOI - PubMed

Publication types

Substances

LinkOut - more resources